Complete Genomics Files for IPO


Complete Genomics Inc., a Mountain View, Calif.-based human genome sequencing company, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol GNOM, with UBS Investment Bank and Jefferies & Co. serving as co-lead underwriters.

The company has raised around $90 million in total VC funding since 2006, from Essex Woodlands Health Ventures, OrbiMed Advisors, Enterprise Partners Venture Capital, OVP Venture Partners, Prospect Venture Partners and Highland Capital Management. www.completegenomics.com

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now

Sign up to our Newsletter

Receive updates from our PE HUB Wire and Top Stories of the Week newsletters:

We will not send you spam, and we don't share your email address with 3rd parties.